Ledger.Open graph →
SEC Form D · filed June 4, 2014

Ohr Pharmaceutical Inc

Offering
$25.2M
Sold
$10.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Arlene Coyle · SEATTLE, WADirectorSteve Heaps · SEATTLE, WADirectorMatt Hulett · SEATTLE, WADirectorWilliam Mcaleer · SEATTLE, WADirectorJames Filsinger · SEATTLE, WAExec · DirectorR. S. Macphee · Boston, MAExec · DirectorRobert E. Howard Iv · Dallas, TXExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗